During the past decade, Northern California Melanoma Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern California Melanoma Center" #1 sponsor was "Northern California Melanoma Center" with 2 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Cosmo Bioscience" with 1 trials sponsored, "Lynn E. Spitler, MD" with 1 trials sponsored and "Synta Pharmaceuticals Corp." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern California Melanoma Center" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Melanoma Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Northern California Melanoma Center" are "Melanoma" (2 trials), "Metastatic Malignant Melanoma" (2 trials), "Malignant Melanoma" (1 trials), "Stage IIIB Skin Melanoma" (1 trials) and "Stage IIIC Skin Melanoma" (1 trials). Many other conditions were trialed in "Northern California Melanoma Center" in a lesser frequency.

Most popular intervention types in "Northern California Melanoma Center" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abraxane" (1 trials), "Avastin" (1 trials), "CB-10-01 (Transgenic Lymphocyte Immunization)" (1 trials), "Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)" (1 trials) and "MDX-010 (CTLA-4)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northern California Melanoma Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Northern California Melanoma Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Northern California Melanoma Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northern California Melanoma Center, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".